DBT in Borderline Personality Disorder

The recruitment status of this study is unknown because the information has not been verified recently.

Verified November 2005 by Bronx VA Medical Center.
Recruitment status was Recruiting

Sponsor:

Information provided by:

Bronx VA Medical Center

ClinicalTrials.gov Identifier:

NCT00252031

First received: November 9, 2005

Last updated: November 17, 2005

Last verified: November 2005

History of Changes

Purpose

Subjects will receive a 6-month course of DBT, consisting of one 90-minute group and one 60-minute individual session per week as well as telephone availability of the individual therapist.

Condition	Intervention
Borderline Personality Disorder	Behavioral: Dialectical Behavioral Therapy


Study Type:	Interventional
Study Design:	Allocation: Non-Randomized Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment
Official Title:	Dialectical Behavioral Therapy for Patients With Borderline Personality Disorder

Resource links provided by NLM:

MedlinePlus related topics: Personality Disorders

U.S. FDA Resources

Further study details as provided by Bronx VA Medical Center:

Primary Outcome Measures:

Measures of parasuicidal behavior, suicidal ideation, mood and emotion, dissociation and health care utilization at baseline, 3 months, 6 months and 9 months

Secondary Outcome Measures:

Measures of cognitive processing at baseline and 6 months

Eligibility


Ages Eligible for Study:	18 Years to 60 Years (Adult)
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria: Is a male or female between 18 and 60 who meets criteria for Borderline Personality Disorder and has had at least 2 prior instances of suicidal or parasuicidal behavior. Either is off psychotropic drugs or is on a stable medication regimen. (During the study, psychotropic medications will be prescribed by a psychiatrist in the Mood and Personality Disorders Group.)

Exclusion Criteria: Meets criteria for Schizophrenia, Bipolar Disorder, Mental Retardation or current or recent Substance Dependence. Subjects also should not currently be in individual psychotherapy. (Case management and work therapy programs are allowed.)

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00252031

Contacts


Contact: Emily Hart	212-241-0441	mpgroup@mssm.edu

Locations


United States, New York
Bronx VA Medical Center	Recruiting
Bronx, New York, United States, 10468

Sponsors and Collaborators

Bronx VA Medical Center

Investigators


Principal Investigator:	Marianne Goodman, MD	Bronx VA Medical Center/Mount Sinai School of Medicine

More Information


ClinicalTrials.gov Identifier:	NCT00252031 History of Changes
Other Study ID Numbers:	3277-02-0002
Study First Received:	November 9, 2005
Last Updated:	November 17, 2005
Health Authority:	United States: Federal Government

Keywords provided by Bronx VA Medical Center:


Borderline Personality Disorder BPD Dialectical Behavior Therapy DBT

Additional relevant MeSH terms:


Disease Personality Disorders Borderline Personality Disorder Pathologic Processes Mental Disorders

ClinicalTrials.gov processed this record on September 26, 2016

To Top